Brian Jovanovic, CEO of Bovis Pharmaceuticals, LLC, discusses viral compound BOV-23, which the company says has shown effectiveness against other influenza viruses in vivo animal tests. Bovis is optimistic that BOV-23 will be effective against the new swine flu influenza virus.
This is a great news. Hopefully this will be noticed by someone who can help and speed up the process.
Thank you !
bdiamond47 2 years ago